Latest filing published 11 Jul 2017 for Abbott Laboratories, €139k.
Filings by Michael T. Rousseau span 2 companies, the busiest being St Jude Medical Inc and Abbott Laboratories. Between 15 December 2012 and 7 July 2017, the trades on record add up to 18 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 11 July 2017 with a share grant (€139k) in Abbott Laboratories. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations